Full-Time

Biomarker Clinical Assay Lead

Manager

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$99.9k - $166.5kAnnually

+ Bonus

Mid, Senior

Bothell, WA, USA + 1 more

More locations: La Jolla, San Diego, CA, USA

On Premise work location; relocation assistance may be available.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • PhD with 2+ years of industry or clinical laboratory experience in Oncology biomarker assay development, assay validation, and implementation within clinical trials employing a broad range of platform technologies (e.g., NGS, IHC, PCR, FISH, flow cytometry, other cell based and circulating biomarker technologies) OR
  • MS with 4+ years of industry or clinical laboratory experience in Oncology biomarker assay development, assay validation, and implementation within clinical trials employing a broad range of platform technologies (e.g., NGS, IHC, PCR, FISH, flow cytometry, other cell based and circulating biomarker technologies) OR
  • BS with 7+ years of industry or clinical laboratory experience in Oncology biomarker assay development, assay validation, and implementation within clinical trials employing a broad range of platform technologies (e.g., NGS, IHC, PCR, FISH, flow cytometry, other cell based and circulating biomarker technologies)
  • Strong track record of publications and/or conference presentations demonstrating recognized subject matter expertise in one or more of these areas: IHC, Flow Cytometry, and Molecular Oncology (NGS) assays
  • Extensive knowledge of clinical laboratory regulatory and compliance requirements (e.g., GCLP, CAP, CLIA) for fit for purpose biomarker assay oversight within oncology clinical trials.
  • Strong verbal and written communication skills
  • Clinical Lab Science (CLS) or American Society of Clinical Pathologist (ASCP) certification
Responsibilities
  • Provide biomarker bioanalytical assay technical and operational expertise to Study Teams to ensure delivery of high-quality clinical biomarker data.
  • Lead novel assay development and timely availability of fit-for-purpose oncology clinical biomarker assays to clinical Study Teams.
  • Troubleshoot/resolve complex technical/logistical issues at vendors.
  • Evaluate complex data critically, e.g., evaluates aberrant results, data trends and guide team in broader interpretation of data.
  • Function as key point of contact with external commercial or academic clinical laboratories, as well as internal clinical labs, with oversight responsibilities for agreements, work plans, budget and invoices, assay transfer, assay validation, sample analyses, data transfers and overall data quality.
  • Lead and provide technical support for selection, qualification, and periodic audits of CRO laboratories supporting clinical trial biomarker assays.
  • Coordinate with Study Teams and clinical operations to ensure appropriate biomarker sample handling and processing steps are appropriately described in the clinical trial Laboratory Manual.
  • Contribute to the biomarker CRF selection/development; lead the data transfer specific development with internal/external biomarker laboratories and internal data management group.
  • Lead and contribute to the ongoing development of best practice processes and templates. Lead / sponsor sub-teams or initiatives toward continuous improvement. Provide strategic direction as it relates to internal, cross-function and external continuous improvement efforts.
  • Maintain up-to-date knowledge of biomarker assay technologies and clinical laboratory standards, regulatory guidance (e.g., GLP, GCLP), and compliance.
  • Provide subject matter expertise and guidance to colleagues.
  • Lead / co-lead complex pilot studies and projects across preclinical Pfizer Oncology enterprise.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?